Follow
Helena Carén
Title
Cited by
Cited by
Year
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
H Carén, F Abel, P Kogner, T Martinsson
Biochemical Journal 416 (2), 153-159, 2008
3202008
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
H Carén, H Kryh, M Nethander, RM Sjöberg, C Träger, S Nilsson, ...
Proceedings of the National Academy of Sciences 107 (9), 4323-4328, 2010
2322010
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
SH Stricker, A Feber, PG Engström, H Carén, KM Kurian, Y Takashima, ...
Genes & development 27 (6), 654-669, 2013
1312013
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous …
H Carén, J Erichsen, L Olsson, C Enerbäck, RM Sjöberg, J Abrahamsson, ...
BMC genomics 9 (1), 1-13, 2008
1262008
Sense-antisense lncRNA pair encoded by locus 6p22. 3 determines neuroblastoma susceptibility via the USP36-CHD7-SOX9 regulatory axis
T Mondal, PK Juvvuna, A Kirkeby, S Mitra, ST Kosalai, L Traxler, ...
Cancer cell 33 (3), 417-434. e7, 2018
1132018
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
G Mazor, L Levin, D Picard, U Ahmadov, H Carén, A Borkhardt, ...
Cell death & disease 10 (3), 1-14, 2019
1022019
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
H Carén, A Djos, M Nethander, RM Sjöberg, P Kogner, C Enström, ...
BMC cancer 11 (1), 1-11, 2011
1002011
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death
K Ejeskär, C Krona, H Carén, F Zaibak, L Li, T Martinsson, PA Ioannou
BMC cancer 5 (1), 1-14, 2005
982005
Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest
H Carén, SH Stricker, H Bulstrode, S Gagrica, E Johnstone, TE Bartlett, ...
Stem cell reports 5 (5), 829-842, 2015
952015
Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest
H Carén, SH Stricker, H Bulstrode, S Gagrica, E Johnstone, TE Bartlett, ...
Stem cell reports 5 (5), 829-842, 2015
952015
Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy
T Martinsson, T Eriksson, J Abrahamsson, H Caren, M Hansson, ...
Cancer research 71 (1), 98-105, 2011
852011
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
A Djos, T Martinsson, P Kogner, H Carén
Molecular cancer 11 (1), 1-13, 2012
832012
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
A Wenger, S Ferreyra Vega, T Kling, TO Bontell, AS Jakola, H Carén
Neuro-oncology 21 (5), 616-627, 2019
722019
Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
H Carén, S Fransson, K Ejeskär, P Kogner, T Martinsson
British journal of cancer 97 (10), 1416-1424, 2007
702007
COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
AG Asting, H Carén, M Andersson, C Lönnroth, K Lagerstedt, K Lundholm
BMC cancer 11 (1), 1-10, 2011
662011
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
M Olsson, S Beck, P Kogner, T Martinsson, H Carén
Epigenetics 11 (1), 74-84, 2016
652016
The good, the bad and the ugly: epigenetic mechanisms in glioblastoma
H Carén, SM Pollard, S Beck
Molecular Aspects of Medicine 34 (4), 849-862, 2013
652013
The dynamics of DNA methylation covariation patterns in carcinogenesis
AE Teschendorff, X Liu, H Caren, SM Pollard, S Beck, M Widschwendter, ...
PLoS computational biology 10 (7), e1003709, 2014
612014
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
K Thorell, A Bergman, H Carén, S Nilsson, P Kogner, T Martinsson, F Abel
BMC medical genomics 2 (1), 1-13, 2009
572009
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
H Kryh, H Carén, J Erichsen, RM Sjöberg, J Abrahamsson, P Kogner, ...
BMC genomics 12 (1), 1-11, 2011
492011
The system can't perform the operation now. Try again later.
Articles 1–20